Publicaciones en colaboración con investigadores/as de University Medical Center Utrecht (6)

2024

  1. Nivolumab with or without ipilimumab in patients with recurrent or metastatic cervical cancer (CheckMate 358): a phase 1–2, open-label, multicohort trial

    The Lancet Oncology, Vol. 25, Núm. 5, pp. 588-602

2022

  1. European experts consensus: BRCA/homologous recombination deficiency testing in first-line ovarian cancer

    Annals of Oncology, Vol. 33, Núm. 3, pp. 276-287

2017

  1. Distinct populations of inflammatory fibroblasts and myofibroblasts in pancreatic cancer

    The Journal of experimental medicine, Vol. 214, Núm. 3, pp. 579-596

  2. Safety and efficacy of single-agent bevacizumab-containing therapy in elderly patients with platinum-resistant recurrent ovarian cancer: Subgroup analysis of the randomised phase III AURELIA trial

    Gynecologic Oncology, Vol. 144, Núm. 1, pp. 65-71

2015

  1. Organoid models of human and mouse ductal pancreatic cancer

    Cell, Vol. 160, Núm. 1-2, pp. 324-338

2009

  1. What keeps a palliative medicine physician so busy with patients? Time expenditure in palliative care

    Palliative Medicine